Triazolam Tablet
Product Images NDC 70771-1576

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 70771-1576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.125 mg Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 01)

0.125 mg  Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 01)
Label for Triazolam Tablets USP, 0.125 mg oral tablets by Zydus Lifesciences Limited. The label indicates a package of 100 tablets, prescription only. It includes storage instructions and pharmacist dispensing information. The label shows the product is made in India and lists dosage and safety guidance.*
FDA Label Image

0.25 mg Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 02)

0.25 mg Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 02)
Triazolam Tablets, USP 0.25 mg oral tablets by Zydus Lifesciences Limited. The label indicates 100 tablets in the package, with instructions for pharmacist dispensing and storage conditions. The container is designed to be light-resistant and the product is prescription-only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.